Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Scribe Therapeutics
1150 Marina Village Pkwy.
Alameda, CA 94501

Scribe Therapeutics is a molecular engineering company focused on building best-in-class in vivo therapies to permanently treat the underlying cause of disease. Founded by CRISPR inventors and leading molecular engineers Benjamin Oakes, Brett Staahl, David Savage, and Jennifer Doudna, Scribe is overcoming the limitations of current genome editing technologies by developing custom engineered enzymes and delivery modalities as part of a proprietary, evergreen platform for CRISPR-based genetic medicine. The company is backed by leading individual and institutional investors including Andreessen Horowitz.

Key Contact
Benjamin Oakes
Funding Events

10/07/20 $20,000,000 Series A Biogen Idec
03/31/21 $100,000,000 Series B Andreessen Horowitz
Avoro Capital Advisors
Menlo Ventures
OrbiMed Advisors
Perceptive Advisors
RA Capital Management
T. Rowe Price Associates
Wellington Capital Management

Featured Reading